Replies to post #358620 on NorthWest Biotherapeutics Inc (NWBO)

[Sir Pumpernickel]

Great Post ATLnsider !! A lot of folks like to claim that UCLA uses "their own brand" of DC Vaccine!! This ought to clear that up for them!!!!
Pumpernickel on a shutdown working overtime YaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaWWWHHHHOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

[Just The Facts Jack]

Yes, that is one reference. However, when you go to the actual clinicaltrials.gov web site you will see that in the official trial description they go out of their way not to use the name DCVax. Even in the space where the web site provides an opportunity to list alternative names, UCLA provided multiple alternatives for Pembrolizumab, i.e., "Keytruda", but chose not to list DCVax. Instead they just used a generic term throughout. Isn't that interesting? Now why would they do that on the official trial designation?

I'm not surprised there are a few old references to DCVax on the Jonsson web site and in old PowerPoint slides, but there's no DCVax to be found in the official clinical trials record. Not a good indicator, in my book, since you insist on bringing it up.

link